Webhaber
AbbVie's blockbuster drug Humira finally loses its 20-year, $200 billion monopoly

AbbVie's blockbuster drug Humira finally loses its 20-year, $200 billion monopoly

U.S. doctors can now choose Amjevita instead, the first of several close copies of the popular rheumatoid arthritis drug expected this year. But industry-watchers warn consumer savings may be limited.

Npr Npr | Go to detail of news source

Npr, Benzer haberler

Npr States are getting $50 billion in opioid cash. And it's an issue in governor's races States are getting $50 billion in opioid cash. And it's an issue in governor's races
Npr Tesla's profits soared to a record – but challenges are mounting Tesla's profits soared to a record – but challenges are mounting
Npr Pope Francis visits the Democratic Republic of Congo in first papal trip since 1985 Pope Francis visits the Democratic Republic of Congo in first papal trip since 1985
Npr Nearly 6-pound 'Toadzilla' found in Australia breaks the record for largest toad Nearly 6-pound 'Toadzilla' found in Australia breaks the record for largest toad
Npr Survey shows a lack of Holocaust awareness in the country that was home to Anne Frank Survey shows a lack of Holocaust awareness in the country that was home to Anne Frank
Npr The U.S. economy ended 2022 on a high note. This year is looking different The U.S. economy ended 2022 on a high note. This year is looking different